Raras
Buscar doenças, sintomas, genes...
Ceratoconjuntivite atópica
ORPHA:163934CID-10 · H16.2CID-11 · 9A60.0YDOENÇA RARA

A queratoconjuntivite atópica é uma doença alérgica rara e crônica que afeta a córnea (a parte transparente do olho) e a conjuntiva (a membrana que reveste a parte branca do olho e a pálpebra por dentro). Ela pode ocorrer em qualquer idade. Os sintomas incluem coceira intensa, sensação de ardência, olhos vermelhos, sensibilidade à luz e inchaço. Em casos mais graves, podem surgir feridas (úlceras) na córnea, que, se não tratadas, podem levar à cegueira. Essa condição é frequentemente associada à dermatite atópica (uma doença alérgica da pele).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A queratoconjuntivite atópica é uma doença alérgica rara e crônica que afeta a córnea (a parte transparente do olho) e a conjuntiva (a membrana que reveste a parte branca do olho e a pálpebra por dentro). Ela pode ocorrer em qualquer idade. Os sintomas incluem coceira intensa, sensação de ardência, olhos vermelhos, sensibilidade à luz e inchaço. Em casos mais graves, podem surgir feridas (úlceras) na córnea, que, se não tratadas, podem levar à cegueira. Essa condição é frequentemente associada à dermatite atópica (uma doença alérgica da pele).

Pesquisas ativas
2 ensaios
8 total registrados no ClinicalTrials.gov
Publicações científicas
410 artigos
Último publicado: 2026 Mar 18

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
15.0
Europe
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H16.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
8 sintomas
❤️
Coração
1 sintomas
🧬
Pele e cabelo
1 sintomas

+ 5 sintomas em outras categorias

Características mais comuns

90%prev.
Ceratoconjuntivite seca
Muito frequente (99-80%)
90%prev.
Opacidade corneana
Muito frequente (99-80%)
90%prev.
Pele seca
Muito frequente (99-80%)
90%prev.
Ceratite
Muito frequente (99-80%)
55%prev.
Neovascularização corneana
Frequente (79-30%)
55%prev.
Fotofobia
Frequente (79-30%)
15sintomas
Muito frequente (4)
Frequente (9)
Ocasional (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 15 características clínicas mais associadas, ordenadas por frequência.

Ceratoconjuntivite secaKeratoconjunctivitis sicca
Muito frequente (99-80%)90%
Opacidade corneanaCorneal opacity
Muito frequente (99-80%)90%
Pele secaDry skin
Muito frequente (99-80%)90%
CeratiteKeratitis
Muito frequente (99-80%)90%
Neovascularização corneanaCorneal neovascularization
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico410PubMed
Últimos 10 anos162publicações
Pico202125 papers
Linha do tempo
2026Hoje · 2026🧪 2007Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 31
2Fase 22
1Fase 11
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ceratoconjuntivite atópica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

8 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
164 papers (10 anos)
#1

Atopic Keratoconjunctivitis: From Molecular Mechanisms to Clinical Implications.

Survey of ophthalmology2026 Mar 17

Atopic keratoconjunctivitis (AKC) is a chronic, bilateral inflammatory disease of the ocular surface that primarily affects young adults with a history of atopic dermatitis, asthma, or allergic rhinitis. AKC is considered the most severe form of ocular allergy and can result in serious complications that threaten vision, such as corneal ulceration, neovascularization, and scarring. Genetic predisposition, through regulatory genes that impact skin barrier function, immune system regulation, and allergic responses, plays a crucial role in the development and severity of AKC. Recent research has highlighted the roles of epithelial barrier dysfunction, gastrointestinal and eyelid/conjunctival dysbiosis, Th2-driven cytokines, and eosinophilic inflammation in disease perpetuation. Diagnosing AKC requires a high level of suspicion, careful integration of clinical signs, and a thorough assessment of coexisting atopic conditions. Management is often challenging and involves a stepwise approach, beginning with topical antihistamines and mast cell stabilizers, progressing to corticosteroids, calcineurin inhibitors, and, in severe or refractory cases, systemic immunosuppressive therapy or surgical intervention. Novel therapies, including biologics targeting IL-4 and IL-13, show promise in selected patients. A multidisciplinary approach and long-term follow-up are crucial for minimizing complications and preserving visual function. This review provides a comprehensive update on the epidemiology, clinical manifestations, immunopathogenesis, diagnostic approach, and therapeutic strategies for AKC.

#2

Progressive Keratoconus as a Complication of Atopic Keratoconjunctivitis: A Case Report.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti2026

Presentation of a  case report demonstrating the complexity of care for a  patient with atopic keratoconjunctivitis (AKC), including the management of complications such as corneal ulceration, development of keratoconus, corticosteroid-induced intraocular pressure elevation, and cataract formation. We describe a case of a 52-year-old male with a marginal corneal ulcer within the context of atopic blepharokeratoconjunctivitis, focusing on complications and the need for intensive local and systemic therapy to stabilize the disease.  Intensive therapy led to a gradual improvement of the disease. Corneal cross-linking stabilized keratoconus, intraocular pressure elevation was successfully managed with anti-glaucoma medication, and cataract surgery resulted in a significant improvement of visual function.  This case report highlights the importance of early diagnosis and the need for long-term, multidisciplinary care in patients with AKC. Regular follow-up examinations, patient education, and a  combination of local, systemic, and surgical therapy are essential in order to prevent complications and stabilize the disease.

#3

Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic Keratoconjunctivitis.

The ocular surface2026 Feb 25

To investigate the relationship between the cytokine levels in the tear fluid and the severity of ocular surface disease in patients with atopic dermatitis (AD) and atopic keratoconjunctivitis (AKC). Tear fluid was collected from 104 AD patients with stratified AKC severity and the healthy controls, who all underwent ophthalmological examination. Cytokine levels in tear fluid were analyzed with Luminex multiplex assays. Increased levels of eotaxin-3, IFN-β, IFN-γ, IL-1β, IL-13, IL-15, IL-17A, IL-2, IL-4, IL-6, IL-8, MCP-4, MIP-1α, MIP-1β, MMP-9, MPIF-1 and MPO were observed in moderate-severe AKC group and IL-6, IL-8 and IFN-γ was associated with AKC severity. The participants with AKC had higher frequencies of atopic comorbidities and the severity of AD was associated with more severe AKC. AKC severity was associated with AD severity, more atopic comorbidities, and increased levels of tear fluid cytokines associated with Th1, -2 and -3 immune response.

#4

Ocular Allergy Within the Framework of the EAACI Nomenclature of Allergic Diseases and Hypersensitivity Reactions.

Allergy, asthma &amp; immunology research2026 Jan

Ocular allergy encompasses a heterogeneous group of diseases with overlapping clinical features and complex immunopathological mechanisms. This often creates challenges in classification and, consequently, in optimizing patient management. The nomenclature published in 2023 by the European Academy of Allergy and Clinical Immunology (EAACI) addresses these issues by redefining these conditions and linking clinical phenotypes and environmental modifiers to underlying types of hypersensitivity. This framework enhances diagnostic precision and supports mechanism-guided management. This article applies the EAACI approach based on hypersensitivity types to ocular allergy. The examples addressed include seasonal and perennial allergic conjunctivitis, driven mainly by type I and IV hypersensitivity reactions; vernal and atopic keratoconjunctivitis, involving mixed type I, IVb and IVa pathways; giant papillary conjunctivitis, a tissue-driven type V reaction; and contact blepharoconjunctivitis, a type IVa delayed hypersensitivity reaction with additional components. Distinct endotypes-such as local or acute allergic conjunctivitis, dupilumab-induced ocular disease, and vernal keratoconjunctivitis/atopic keratoconjunctivitis overlap-further illustrate heterogeneity, with the ocular surface microbiome emerging as a modifier. Diagnostics are increasingly aligning with mechanisms, and the EAACI framework translates this complexity into a mechanism-indexed map; this supports the selection of responders for targeted interventions while minimizing overtreatment.

#5

A Case of Distinctive Corneal Opacity Following Ciliary Sulcus Ahmed Tube Insertion in a Patient With Glaucoma Associated With Atopic Dermatitis.

Cureus2026 Jan

Corneal and conjunctival inflammation associated with atopic dermatitis is classified as atopic keratoconjunctivitis, and eye rubbing related to ocular itching is known to cause various ocular complications. We report a case of a Japanese man in his 40s with open-angle glaucoma associated with atopic dermatitis who developed a characteristic corneal opacity after Ahmed Glaucoma Valve (AGV) implantation with ciliary sulcus tube insertion. Despite the absence of persistent anatomical tube-corneal touch on serial examinations, a stellate corneal opacity developed at a site precisely corresponding to the tube tip during a period of exacerbated atopic dermatitis accompanied by frequent eye rubbing. Anterior-segment optical coherence tomography (OCT) consistently demonstrated a measurable distance between the tube and the corneal endothelium. Intermittent tube-corneal contact induced by corneal deformation during eye rubbing was hypothesized to be a plausible contributing factor. This case provides a clinical lesson that corneal damage related to the tube may occur even after sulcus tube insertion in patients with atopic glaucoma, highlighting the importance of careful postoperative corneal monitoring and appropriate management of atopic dermatitis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC151 artigos no totalmostrando 160

2026

Atopic Keratoconjunctivitis: From Molecular Mechanisms to Clinical Implications.

Survey of ophthalmology
2026

Progressive Keratoconus as a Complication of Atopic Keratoconjunctivitis: A Case Report.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
2026

Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic Keratoconjunctivitis.

The ocular surface
2026

Ocular Allergy Within the Framework of the EAACI Nomenclature of Allergic Diseases and Hypersensitivity Reactions.

Allergy, asthma &amp; immunology research
2026

A Case of Distinctive Corneal Opacity Following Ciliary Sulcus Ahmed Tube Insertion in a Patient With Glaucoma Associated With Atopic Dermatitis.

Cureus
2025

Clinical profile of ocular allergy and its impact on quality of life in Brazilian children and adolescents.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2026

Acute Corneal Hydrops: A Comprehensive Review of Diagnosis, Treatment, and Outcomes.

Cornea
2026

Janus kinase inhibitors are effective in atopic keratoconjunctivitis treatment and not only in managing dupilumab-induced ocular adverse events.

The British journal of dermatology
2026

Periostin promotes inflammation and neovascularization in atopic keratoconjunctivitis.

The Journal of allergy and clinical immunology
2025

[A case of atopic keratoconjunctivitis complicated by non-infectious corneal ulcer in a child].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms.

Clinical reviews in allergy &amp; immunology
2025

Emerging concepts in atopic dermatitis and atopic keratoconjunctivitis.

Current opinion in allergy and clinical immunology
2025

Where eye meets body part 2: uniting allergy pathways in ocular and atopic disease - T cells take the lead.

Current opinion in allergy and clinical immunology
2025

Topical Innovation: A Report on Epinastine Eyelid Cream for Patients With Mild Atopic Keratoconjunctivitis.

Cureus
2026

Tomographic and biomechanical refractive findings in ocular pediatric allergy.

Japanese journal of ophthalmology
2025

Shield ulcer in keratoconus in the absence of atopic or vernal kerato-conjunctivitis.

GMS ophthalmology cases
2025

Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?

The Journal of dermatological treatment
2025

Ranking the efficacy of topical treatments for ocular allergy: A network meta-analysis of current evidence.

The ocular surface
2025

Limbal Stem Cell Deficiency Induced by Prolonged Use of Topical 0.03% Tacrolimus Ointment in a Patient With Atopic Keratoconjunctivitis.

Eye &amp; contact lens
2025

Effects of Allergic Predisposition on Corneal Biomechanical Properties in Normal Corneas: A Retrospective Study.

Juntendo medical journal
2025

Atopic Dermatitis and Atopic Keratoconjunctivitis: New Insights in the Analyses of Microbiota and Probiotic Effect.

International journal of molecular sciences
2025

New grading classification for paediatric atopic keratoconjunctivitis.

The British journal of ophthalmology
2024

The Role of In Vivo Confocal Microscopy in Ocular Allergies.

Turkish journal of ophthalmology
2025

Eroded Gore-Tex Scleral Sutures and Endophthalmitis in Atopic Keratoconjunctivitis.

Ophthalmology. Retina
2025

Use of explainable AI on slit-lamp images of anterior surface of eyes to diagnose allergic conjunctival diseases.

Allergology international : official journal of the Japanese Society of Allergology
2024

Unraveling the complexity - Insights and interventions of refractory vernal keratoconjunctivitis.

The ocular surface
2024

Resolution of Plaque Keratopathy in a Patient with Atopic Keratoconjunctivitis After Treatment with Leflunomide.

Ocular immunology and inflammation
2024

Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice.

Journal of clinical medicine
2024

Dupilumab-associated ocular surface disease or atopic keratoconjunctivitis not improved by dupilumab? Upadacitinib may clarify the dilemma: A case report.

Skin health and disease
2024

Electroretinographic Evaluations Using Skin Electrode of Eyes with Bleb-Related Endophthalmitis Following Vitrectomy with 0.025% Povidone Iodine Irrigation.

International medical case reports journal
2024

Atopic Keratoconjunctivitis: Pathophysiology, Clinic, and Potential New Therapeutic Concepts.

Klinische Monatsblatter fur Augenheilkunde
2024

Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis.

International ophthalmology
2024

A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast.

Ophthalmology and therapy
2024

Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia.

The ocular surface
2024

[New and future treatment approaches for allergic conjunctivitis].

Die Ophthalmologie
2024

[Current aspects of vernal and atopic keratoconjunctivitis].

Die Ophthalmologie
2024

Comprehensive evaluation of ocular complications in atopic dermatitis: insights from a contemporary cohort study in Korean population.

International journal of dermatology
2023

Classification of Subtypes of Vernal Keratoconjunctivitis by Cluster Analysis Based on Clinical Features.

Clinical ophthalmology (Auckland, N.Z.)
2023

[Allergic and immunopathological diseases of the ocular surface].

Orvosi hetilap
2023

Biomarkers of ocular allergy and dry eye disease.

Romanian journal of ophthalmology
2024

Eosinophil extracellular trap formation in the giant papillae of atopic keratoconjunctivitis and vernal keratoconjunctivitis.

Allergology international : official journal of the Japanese Society of Allergology
2023

Indications and outcomes of keratoplasty ≤ 5.5 mm diameter ("mini-keratoplasty").

BMC ophthalmology
2024

Bilateral Corneal Panni Associated with Limbal Inclusion Cysts in the Left Eye in a Patient with Atopic Keratoconjunctivitis.

Ocular immunology and inflammation
2023

Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis.

Current opinion in allergy and clinical immunology
2023

Early Postoperative Therapeutic Scleral Lens Intervention for Penetrating Keratoplasty Complications in Atopic Keratoconjunctivitis.

Eye &amp; contact lens
2023

[Differential diagnoses of ocular mucous membrane pemphigoid].

Die Ophthalmologie
2023

IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice.

Allergology international : official journal of the Japanese Society of Allergology
2022

Positive regulation of innate immune response by miRNA-let-7a-5p.

Frontiers in genetics
2023

Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye.

Allergology international : official journal of the Japanese Society of Allergology
2023

Topical cyclosporine A 1 mg/ml for atopic keratoconjunctivitis: Five-year case series of 99 children and young people.

Acta ophthalmologica
2022

Executive summary: Japanese guidelines for allergic conjunctival diseases 2021.

Allergology international : official journal of the Japanese Society of Allergology
2022

Analysis of Cytokine Production Profiles of Local and Systemic Lymphocytes in Sick Building Syndrome Compared with Ocular Allergy.

Journal of asthma and allergy
2022

Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis.

The ocular surface
2023

Effect of Anti-allergic Therapy on Quality of Life in Children with Allergic Conjunctivitis and Their Parents.

Ocular immunology and inflammation
2023

Effects of Antihistamine-Releasing Contact Lenses on Severe Allergic Conjunctivitis.

Ocular immunology and inflammation
2022

Combination Therapy of 0.1% Fluorometholone and 0.05% Azelastine in Eyes with Severe Allergic Conjunctival Diseases: A Randomized Controlled Trial.

Journal of clinical medicine
2022

Ocular allergy in children and adolescents.

Allergologia et immunopathologia
2022

Visual Outcomes of Microkeratome-Assisted Anterior Lamellar Keratoplasty in Keratoconus: 5-Year Results.

Journal of ophthalmology
2022

Atopic keratoconjunctivitis alleviated with dupilumab.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2022

Lirentelimab for severe and chronic forms of allergic conjunctivitis.

The Journal of allergy and clinical immunology
2022

Role of Damage-Associated Molecular Patterns (DAMPs/Alarmins) in Severe Ocular Allergic Diseases.

Cells
2022

Importance of Corneal Angiography in Subclinical Limbitis in a Case of Atopic Keratoconjunctivitis.

Cornea
2022

Dysbiosis of Ocular Surface Microbiota in Patients With Refractive Allergic Conjunctival Diseases.

Cornea
2022

Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus.

Cornea
2022

Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials.

The British journal of dermatology
2021

[TREATMENT OF SEVERE ALLERGIC CONJUNCTIVITIS IN JAPAN, FOCUS ON IMMUNOSUPPRESSIVE EYE DROPS].

Arerugi = [Allergy]
2021

Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.

Immunity, inflammation and disease
2021

Psychosocial impact of ocular surface allergic inflammatory disorders.

Current opinion in allergy and clinical immunology
2021

The effects of the COVID-19 pandemic on the treatment of allergic eye diseases.

Current opinion in allergy and clinical immunology
2021

Association Between Atopic Keratoconjunctivitis and the Risk of Recurrent Corneal Erosion.

Frontiers in medicine
2021

Dual inhibition of complement component 5 and leukotriene B4 by topical rVA576 in atopic keratoconjunctivis: TRACKER phase 1 clinical trial results.

Orphanet journal of rare diseases
2021

Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents.

JAMA ophthalmology
2021

Vernal keratoconjunctivitis: An update.

European journal of ophthalmology
2021

The FADS mouse: A novel mouse model of atopic keratoconjunctivitis.

The Journal of allergy and clinical immunology
2021

[PATHOGENESIS AND FUTURE TREATMENT OF SEVERE OCULAR ALLERGIC DISEASES].

Arerugi = [Allergy]
2021

Quantitative evaluation of lipid layer thickness and blinking in children with allergic conjunctivitis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2021

Analysis of the Conjunctival Microbiome in Patients with Atopic Keratoconjunctivitis and Healthy Individuals.

Annals of dermatology
2021

Current Knowledge in Allergic Conjunctivitis.

Turkish journal of ophthalmology
2021

Tear N-glycomics in vernal and atopic keratoconjunctivitis.

Allergy
2021

A polymeric aqueous tacrolimus formulation for topical ocular delivery.

International journal of pharmaceutics
2021

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2021

Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae.

Eye (London, England)
2021

IL-1α antibody inhibits dose-dependent exacerbation of eosinophilic inflammation by crude house-dust-mite antigen in the conjunctiva of an atopic keratoconjunctivitis mouse model.

Current eye research
2020

Japanese guidelines for allergic conjunctival diseases 2020.

Allergology international : official journal of the Japanese Society of Allergology
2020

Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.

The Cochrane database of systematic reviews
2020

Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases.

Japanese journal of ophthalmology
2021

Association between atopic keratoconjunctivitis and the risk of corneal ulcer.

The British journal of ophthalmology
2020

Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension.

Journal of clinical medicine
2021

Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis.

Journal of the American Academy of Dermatology
2021

A case of fungal conjunctivitis with giant papillae treated surgically.

Taiwan journal of ophthalmology
2020

The role of human immunodeficiency virus in the pathogenesis of vernal keratoconjunctivitis-like disease in adults: A demographic and epidemiological study.

Indian journal of ophthalmology
2021

The prevalence of keratoconus in children with allergic eye disease in an Egyptian population.

European journal of ophthalmology
2020

Epidemiological aspects of allergic conjunctivitis.

Allergology international : official journal of the Japanese Society of Allergology
2021

Pulsed oral corticosteroids for the treatment of vernal and atopic keratoconjunctivitis: a management plan.

Eye (London, England)
2020

Pharmacotherapeutic management of atopic keratoconjunctivitis.

Expert opinion on pharmacotherapy
2021

Association between atopic keratoconjunctivitis and the risk of keratoconus.

Acta ophthalmologica
2020

Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases.

Allergology international : official journal of the Japanese Society of Allergology
2020

Prospective Clinical Study of Keratoconus Progression in Patients Awaiting Corneal Cross-linking.

Cornea
2021

Ocular surface disease associated with dupilumab treatment for atopic diseases.

The ocular surface
2020

Potential Biomarkers for Allergic Conjunctival Diseases.

Eye &amp; contact lens
2020

Combination of Two Rapid Ophthalmic Test Kits for Improved Diagnosis in Cases of Severe Binocular Conjunctivitis.

Diagnostics (Basel, Switzerland)
2022

Clinical characteristics and outcomes of ocular allergy in Thai children.

Asian Pacific journal of allergy and immunology
2020

Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis.

Journal of the European Academy of Dermatology and Venereology : JEADV
2019

Air pollution significantly associated with severe ocular allergic inflammatory diseases.

Scientific reports
2020

Amelioration of conjunctival giant papillae by dupilumab in patients with atopic keratoconjunctivitis.

The journal of allergy and clinical immunology. In practice
2020

Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment.

The British journal of ophthalmology
2019

Recent trends of ocular complications in patients with atopic dermatitis.

Japanese journal of ophthalmology
2019

Topical tacrolimus for allergic eye diseases.

Current opinion in allergy and clinical immunology
2019

Neurotrophic factors and nerve growth factor in ocular allergy.

Current opinion in allergy and clinical immunology
2019

Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

Drugs &amp; aging
2019

Periostin in Eye Diseases.

Advances in experimental medicine and biology
2019

Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.

Current eye research
2019

[Tacrolimus ointment in the management of atopic keratoconjunctivitis].

Journal francais d'ophtalmologie
2019

Tacrolimus ointment in the management of atopic keratoconjunctivitis.

Journal francais d'ophtalmologie
2019

[Application of corticosteroid eye drops for allergic eye diseases in children].

Orvosi hetilap
2019

Diagnosing and managing allergic conjunctivitis in childhood: The allergist's perspective.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2019

The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis.

Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology
2019

Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis.

The ocular surface
2019

Transcriptome profiling of refractory atopic keratoconjunctivitis by RNA sequencing.

The Journal of allergy and clinical immunology
2018

Topical Treatment of Persistent Epithelial Defects with a Matrix Regenerating Agent.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
2018

[Erratum to "Atopic keratoconjunctivitis: One allergy may mask another. A clinical observation with two types of hypersensitivity reactions: IgE-mediated and non-IgE-mediated" J Fr Ophtalmol 2018;41:224-30].

Journal francais d'ophtalmologie
2018

Ocular involvement in atopic disease: a review.

Current opinion in ophthalmology
2019

Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.

Ocular immunology and inflammation
2018

Preclinical characterization and clinical evaluation of tacrolimus eye drops.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2018

Secondary Angle Closure due to Crystalline Lens Dislocation in a Patient with Atopic Dermatitis and Chronic Eye Rubbing.

Case reports in ophthalmology
2018

Atopic keratoconjunctivitis: A diagnostic dilemma-a case report.

Medicine
2018

Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.

Pediatrics
2018

[Atopic keratoconjunctivitis: One allergy may mask another. A clinical observation with two types of hypersensitivity reactions: IgE-mediated and non-IgE-mediated].

Journal francais d'ophtalmologie
2018

[GUIDELINES FOR THE CLINICAL MANAGEMENT OF ALLERGIC CONJUNCTIVAL DISEASE THE POINT OF THE MANAGEMENT WITH USING CONVENTIONAL TOOL AND EYE DROPS].

Arerugi = [Allergy]
2018

Allergic conjunctivitis: current concepts on pathogenesis and management.

Journal of biological regulators and homeostatic agents
2017

Successful Subcutaneous Allergen-Specific Immunotherapy in Refractory Atopic Keratoconjunctivitis: A Case Report.

Case reports in ophthalmology
2017

Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage.

BMJ open ophthalmology
2018

Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease.

Journal of clinical apheresis
2017

Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.

Arquivos brasileiros de oftalmologia
2017

Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice.

Scientific reports
2017

Histamine H1 and H4 receptor expression on the ocular surface of patients with chronic allergic conjunctival diseases.

Allergology international : official journal of the Japanese Society of Allergology
2017

Clinical and allergological analysis of ocular manifestations of sick building syndrome.

Clinical ophthalmology (Auckland, N.Z.)
2017

Ocular Surface Squamous Neoplasia Associated with Atopic Keratoconjunctivitis.

Ocular oncology and pathology
2017

Japanese guidelines for allergic conjunctival diseases 2017.

Allergology international : official journal of the Japanese Society of Allergology
2017

Atopic keratoconjunctivitis complicated by Kocuria koreensis keratitis: the first case.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
2016

Atopic keratoconjunctivitis: long-term results of medical treatment and penetrating keratoplasty.

Arquivos brasileiros de oftalmologia
2018

Clinical Severity and Tear Biomarkers, Eosinophil Cationic Protein and CCL23, in Chronic Allergic Conjunctival Diseases.

Seminars in ophthalmology
2018

Angiographic Evaluation of Inflammation in Atopic Keratoconjunctivitis.

Ocular immunology and inflammation
2017

Clinical Usefulness of Simultaneous Measurement of the Tear Levels of CCL17, CCL24, and IL-16 for the Biomarkers of Allergic Conjunctival Disorders.

Current eye research
2016

Clinical Usefulness of Monitoring Expression Levels of CCL24 (Eotaxin-2) mRNA on the Ocular Surface in Patients with Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis.

Journal of ophthalmology
2016

Therapeutic effect of 0.1% Tacrolimus Eye Ointment in Allergic Ocular Diseases.

Journal of clinical and diagnostic research : JCDR
2016

An update on ocular allergy.

Current opinion in allergy and clinical immunology
2016

[Keratitis - Infectious or Autoimmune?].

Klinische Monatsblatter fur Augenheilkunde
2016

Atopic keratoconjunctivitis with corneal ulcer. Case report.

Romanian journal of ophthalmology
2016

The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases.

The Journal of allergy and clinical immunology
2015

[Treatment of large corneal perforations with acellular multilayer of corneal stromal lenticules harvested from femtosecond laser lenticule extraction].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2015

[Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].

Journal francais d'ophtalmologie
2015

Involvement of Chemokines and a CD4-Positive T Cell Subset in the Development of Conjunctival Secondary Lymphoid Follicles in an Atopic Keratoconjunctivitis Mouse Model.

International archives of allergy and immunology
2016

Atopic Keratoconjunctivitis in Children: Clinical Features and Diagnosis.

Ophthalmology
2015

Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study.

Current opinion in allergy and clinical immunology
2015

Correlations Between Allergen-Specific IgE Serum Levels in Patients With Ocular Allergy.

Cornea
2015

Candida albicans should be considered when managing keratitis in Atopic keratoconjunctivitis.

Acta ophthalmologica
2015

A comprehensive review on vernal keratoconjunctivitis with emphasis on proteomics.

Life sciences
2014

Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops.

Clinical and translational allergy
2015

Spontaneous corneal perforation associated with atopic keratoconjunctivitis: a case series and literature review.

Acta ophthalmologica

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ceratoconjuntivite atópica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ceratoconjuntivite atópica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Atopic Keratoconjunctivitis: From Molecular Mechanisms to Clinical Implications.
    Survey of ophthalmology· 2026· PMID 41856175mais citado
  2. Progressive Keratoconus as a Complication of Atopic Keratoconjunctivitis: A Case Report.
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti· 2026· PMID 41795610mais citado
  3. Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic Keratoconjunctivitis.
    The ocular surface· 2026· PMID 41759910mais citado
  4. Ocular Allergy Within the Framework of the EAACI Nomenclature of Allergic Diseases and Hypersensitivity Reactions.
    Allergy, asthma &amp; immunology research· 2026· PMID 41592536mais citado
  5. A Case of Distinctive Corneal Opacity Following Ciliary Sulcus Ahmed Tube Insertion in a Patient With Glaucoma Associated With Atopic Dermatitis.
    Cureus· 2026· PMID 41531444mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:163934(Orphanet)
  2. MONDO:0015599(MONDO)
  3. GARD:20053(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q55785583(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Ceratoconjuntivite atópica
Compêndio · Raras BR

Ceratoconjuntivite atópica

ORPHA:163934 · MONDO:0015599
Prevalência
1-5 / 10 000
Herança
Not applicable
CID-10
H16.2 · Ceratoconjuntivite
CID-11
Ensaios
2 ativos
Início
All ages
Prevalência
15.0 (Europe)
MedGen
UMLS
C1274788
Repurposing
29 candidatos
amlexanoxhistamine receptor modulator
antazolineantihistamine
azelastinehistamine receptor antagonist
+17 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades